← Leaderboards

Victor H. Engelhard

University Of Virginia Charlottesville

Google Scholar ↗PubMed ↗ORCID ↗

$22,896,814

Attributed

$27,113,139

Total exposure

17

Grants

13

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.9M · FY2005–23

$2M$1.5M$1M$500K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

Funding mix

By agency

NIH$27,113,139 · 17

By mechanism

R01$19,322,226 · 8

T32$5,019,121 · 1

R21$1,632,406 · 4

R37$653,203 · 1

R56$259,911 · 1

P30$226,272 · 2

Top collaborators

Most similar at University Of Virginia Charlottesville

Same institution · by research overlap

Timothy N Bullock$7,542,914
Donald F Hunt$28,953,354

Others in their field

Top investigators on “Base”

Sonia M Thomas · Research Triangle Institute$700,865,642
David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
David Divins · Consortium For Ocean Leadership, Inc$609,772,544
Larry Arthur$521,411,998
Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060

Research focus

BaseT-LymphocyteMelanomaImmunotherapyTumorCellsAntigensImmune ResponseTissuesProteinsResponseImmunityImmuneSourceResearch PersonnelPeptidesSelf ToleranceSolid NeoplasmCancer PatientImmunologyTumor ImmunityImmunotherapeutic AgentCancer CellCancer Immunotherapy

Grant awards (88)

Manipulating microenvironment and vasculature to enhance T cell infiltration into tumors$507,168

R01 · FY2023 · CA · contact PI

Interdisciplinary Training Program in Immunology$430,401

T32 · FY2023 · AI · contact PI

Manipulating microenvironment and vasculature to enhance T cell infiltration into tumors$31,373

R01 · FY2023 · CA · contact PI

Manipulating microenvironment and vasculature to enhance T cell infiltration into tumors$507,168

R01 · FY2022 · CA · contact PI

Interdisciplinary Training Program in Immunology$428,347

T32 · FY2022 · AI · contact PI

Manipulating microenvironment and vasculature to enhance T cell infiltration into tumors$134,987

R01 · FY2022 · CA · contact PI

Manipulating microenvironment and vasculature to enhance T cell infiltration into tumors$655,260

R01 · FY2021 · CA · contact PI

Interdisciplinary Training Program in Immunology$387,494

T32 · FY2021 · AI · contact PI

Manipulating microenvironment and vasculature to enhance T cell infiltration into tumors$479,627

R01 · FY2020 · CA · contact PI

Supplement - Manipulating microenvironment and vasculature to enhance T cell infiltration into tumors$105,729

R01 · FY2020 · CA · contact PI

Manipulating microenvironment and vasculature to enhance T cell infiltration into tumors$517,519

R01 · FY2019 · CA · contact PI

Immunotherapeutic Nanoparticle Delivery to Melanoma With MR-Guided Focused Ultrasound$500,099

R01 · FY2019 · CA

Interdisciplinary Training Program in Immunology$457,056

T32 · FY2019 · AI · contact PI

Immunology/Immunotherapy Program - IMM$37,027

P30 · FY2019 · CA · contact PI

Immunotherapeutic Nanoparticle Delivery to Melanoma With MR-Guided Focused Ultrasound$517,432

R01 · FY2018 · CA

Interdisciplinary Training Program in Immunology$450,064

T32 · FY2018 · AI · contact PI

Immunity to MHC-restricted phosphopeptides in healthy donors and cancer patients$337,529

R01 · FY2018 · CA · contact PI

Immunology/Immunotherapy Program - IMM$36,978

P30 · FY2018 · CA · contact PI

Immunology/Immunotherapy Program - IMM$10,237

P30 · FY2018 · CA · contact PI

Immunology/Immunotherapy Program - IMM$7,344

P30 · FY2018 · CA · contact PI

Immunology/Immunotherapy Program - IMM$6,320

P30 · FY2018 · CA · contact PI

Immunology/Immunotherapy Program - IMM$3,518

P30 · FY2018 · CA · contact PI

Immunology/Immunotherapy Program - IMM$2,865

P30 · FY2018 · CA · contact PI

Immunology/Immunotherapy Program - IMM$2,058

P30 · FY2018 · CA · contact PI

Immunotherapeutic Nanoparticle Delivery to Melanoma With MR-Guided Focused Ultrasound$519,263

R01 · FY2017 · CA

Interdisciplinary Training Program in Immunology$442,920

T32 · FY2017 · AI · contact PI

Immunity to MHC-restricted phosphopeptides in healthy donors and cancer patients$337,529

R01 · FY2017 · CA · contact PI

Immunology/Immunotherapy Program - IMM$34,786

P30 · FY2017 · CA · contact PI

Interdisciplinary Training Program in Immunology$597

T32 · FY2017 · AI · contact PI

Immunotherapeutic Nanoparticle Delivery to Melanoma With MR-Guided Focused Ultrasound$521,056

R01 · FY2016 · CA

Interdisciplinary Training Program in Immunology$438,218

T32 · FY2016 · AI · contact PI

Immunity to MHC-restricted phosphopeptides in healthy donors and cancer patients$336,853

R01 · FY2016 · CA · contact PI

Lymph node-like vasculature and naive T cell infiltration into tumors$171,825

R21 · FY2016 · CA · contact PI

Immunotherapeutic Nanoparticle Delivery to Melanoma With MR-Guided Focused Ultrasound$537,316

R01 · FY2015 · CA

Interdisciplinary Training Program in Immunology$436,751

T32 · FY2015 · AI · contact PI

Immunity to MHC-restricted phosphopeptides in healthy donors and cancer patients$336,853

R01 · FY2015 · CA · contact PI

Lymph node-like vasculature and naive T cell infiltration into tumors$206,190

R21 · FY2015 · CA · contact PI

Lymphatic endothelial cells as inducers of systemic peripheral tolerance$193,225

R21 · FY2015 · AI · contact PI

Fluorescence molecular tomography to study T cell infiltration into tumors$168,788

R21 · FY2015 · CA · contact PI

Immunity to MHC-restricted phosphopeptides in healthy donors and cancer patients$430,054

R01 · FY2014 · CA · contact PI

Interdisciplinary Training Program in Immunology$370,095

T32 · FY2014 · AI · contact PI

Lymphatic endothelial cells as inducers of systemic peripheral tolerance$232,725

R21 · FY2014 · AI · contact PI

Fluorescence molecular tomography to study T cell infiltration into tumors$203,153

R21 · FY2014 · CA · contact PI

Interdisciplinary Training Program in Immunology$398,592

T32 · FY2013 · AI · contact PI

Lymphatic endothelial cells as inducers of systemic peripheral tolerance$259,911

R56 · FY2013 · AI · contact PI

Antigenic Determinants on HLA-B7 and -A2$559,343

R01 · FY2012 · CA · contact PI

Interdisciplinary Training Program in Immunology$390,054

T32 · FY2012 · AI · contact PI

Quality and location of presented Ag as determinants of tumor-specific immunity$366,307

R01 · FY2012 · CA · contact PI

Antigenic Determinants on HLA-B7 and -A2$559,645

R01 · FY2011 · CA · contact PI

Interdisciplinary Training Program in Immunology$388,532

T32 · FY2011 · AI · contact PI

Quality and location of presented Ag as determinants of tumor-specific immunity$366,307

R01 · FY2011 · CA · contact PI

Autoimmune vitiligo and tolerance in the immune response to a melanoma antigen$363,046

R01 · FY2011 · AI · contact PI

Antigenic Determinants on HLA-B7 and -A2$451,153

R01 · FY2010 · CA · contact PI

Quality and location of presented Ag as determinants of tumor-specific immunity$377,734

R01 · FY2010 · CA · contact PI

Autoimmune vitiligo and tolerance in the immune response to a melanoma antigen$366,746

R01 · FY2010 · AI · contact PI

Immunology$25,825

P30 · FY2010 · CA · contact PI

Autoimmune vitiligo and tolerance in the immune response to a melanoma antigen$575,287

R01 · FY2009 · AI · contact PI

Antigenic Determinants on HLA-B7 and -A2$429,529

R01 · FY2009 · CA · contact PI

Quality and location of presented Ag as determinants of tumor-specific immunity$377,646

R01 · FY2009 · CA · contact PI

Immunology$26,316

P30 · FY2009 · CA · contact PI

Antigenic Determinants on HLA-B7 and -A2$379,773

R01 · FY2008 · CA · contact PI

Autoimmune vitiligo and tolerance in the immune response to a melanoma antigen$370,513

R01 · FY2008 · AI · contact PI

Immunology$13,199

P30 · FY2008 · CA · contact PI

Preclinical Study of Peptide Based Human Tumor Vaccines$391,471

R01 · FY2007 · CA · contact PI

Autoimmune vitiligo and tolerance in the immune response to a melanoma antigen$377,720

R01 · FY2007 · AI · contact PI

Immunology$13,199

P30 · FY2007 · CA · contact PI

Preclinical Study of Peptide Based Human Tumor Vaccines$391,420

R01 · FY2006 · CA · contact PI

Antigenic determinants on HLA-B7 and-A2$359,350

R01 · FY2006 · AI · contact PI

Immunology$6,600

P30 · FY2006 · CA · contact PI

Preclinical Study of Peptide Based Human Tumor Vaccines$389,164

R01 · FY2005 · CA

Antigenic determinants on HLA-B7 and-A2$368,056

R01 · FY2005 · AI

Vitiligo in Tyrosinase-specific TCR Transgenic Mice$228,500

R21 · FY2005 · AI

Preclinical Study of Peptide Based Human Tumor Vaccines$376,597

R01 · FY2004 · CA

Antigenic determinants on HLA-B7 and-A2$368,113

R01 · FY2004 · AI

Vitiligo in Tyrosinase-specific TCR Transgenic Mice$228,000

R21 · FY2004 · AI

IDENTIFICATION OF HUMAN MINOR H ANTIGEN PEPTIDES &GENES$370,330

R01 · FY2003 · AI

Antigenic determinants on HLA-B7 and-A2$368,168

R01 · FY2003 · AI

Preclinical Study of Peptide Based Human Tumor Vaccines$365,628

R01 · FY2003 · CA

Antigenic determinants on HLA-B7 and-A2$368,221

R01 · FY2002 · AI

PRECLINICAL STUDY OF PEPTIDE BASED HUMAN TUMOR VACCINES$343,923

R01 · FY2002 · CA

IDENTIFICATION OF HUMAN MINOR H ANTIGEN PEPTIDES &GENES$326,771

R01 · FY2002 · AI

IDENTIFICATION OF HUMAN MINOR H ANTIGEN PEPTIDES &GENES$350,153

R01 · FY2001 · AI

ANTIGENIC DETERMINENTS ON HLA-B7 AND HLA-A2$331,429

R37 · FY2001 · AI

PRECLINICAL STUDY OF PEPTIDE BASED HUMAN TUMOR VACCINES$299,811

R01 · FY2001 · CA

PRECLINICAL STUDY OF PEPTIDE BASED HUMAN TUMOR VACCINES$25,819

R01 · FY2001 · CA

IDENTIFICATION OF HUMAN MINOR H ANTIGEN PEPTIDES &GENES$339,955

R01 · FY2000 · AI

ANTIGENIC DETERMINENTS ON HLA-B7 AND HLA-A2$321,774

R37 · FY2000 · AI

PRECLINICAL STUDY OF PEPTIDE BASED HUMAN TUMOR VACCINES$285,712

R01 · FY2000 · CA